Participants in a self-directed diet program lost significantly more weight by consuming higher amounts of protein and fiber, along with adhering to a personalized and flexible diet plan. Source: SciTech Daily

A new fluorescent imaging probe can for the first time objectively and non-invasively measure loss of smell, clinically known as anosmia. Targeting the olfactory nerve, the new tool has potential to eliminate biopsies used to diagnose certain anosmia conditions and to aid in the development of therapeutic interventions. This research, funded in part by NIBIB, was published in the August issue of The Journal of Nuclear Medicine.

Source: Society of Nuclear Medicine and Molecular Imaging News

 

New research from a Florida State University professor and colleagues explains the mathematics behind how initial predispositions and additional information affect decision making.

The research team’s findings show that when decision makers quickly come to a conclusion, the decision is more influenced by their initial bias, or a tendency to err on the side of one of the choices presented. If decision makers wait to gather more information, the slower decision will be less biased. Source: Florida State University News

A team of NIBIB-funded researchers recently developed an AI platform that can analyze 3D pathology images to predict disease outcomes. Their method had improved performance in predicting prostate cancer outcomes when compared with traditional pathology approaches, such as analysis by expert pathologists using 2D images.

A study funded in part by NIBIB published in Science Advances describes new technology developed by the Rice University lab of bioengineer Jerzy Szablowski that could be a game changer for brain-based gene therapy. The new noninvasive tool can measure expression of gene therapy or endogenous genes in specific brain regions.

Source: Rice University News

A team of undergraduate researchers at UT Tyler have received $481,440 in funding from NIBIB. The focus of their research is developing formulations and algorithms to increase the speed and accuracy of ultrasound imaging so that it might one day be used to treat tumors. Source: KLTV

There are currently no treatments, preventive vaccines, or cures for prion diseases, which can be acquired, like mad cow disease, or inherited, like fatal familial insomnia. But an encouraging new study in mice suggests a potentially promising path for developing a treatment for people with these deadly conditions. Source: NIH Director's Blog

Working with the National Institutes of Health Rapid Acceleration of Diagnostics Tech test validation center, researchers from Atlanta’s Emory University and Grady Health System have helped push hepatitis C testing to new heights, participating in the creation of the first FDA-authorized point-of-care test for the virus. It’s a scientific breakthrough that could affect millions of Americans. Source: https://www.ajc.com/pulse/grady-emory-hep-c-breakthrough-this-device-re…

Due to its high accuracy, lab-based PCR testing is the gold standard for infectious disease diagnostics. Yet PCR's availability is limited, especially in low-resource settings. New research suggests a new kind of test could be more streamlined without sacrificing performance.